CSLLY

CSL LTD

Healthcare · Biotechnology

$132.34 sample

-0.58 (-0.44%) 1D

Market cap

$587.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$132.34 +5.39% 3M daily closessample

141.92119.76

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider sell: Chief Financial Officer
Sep 30INSInsider sell: 10% owner
Sep 23INSInsider sell: Director
Sep 17SECForm 144 filed
Sep 10INSInsider sell: EVP, Operations
Sep 01INSInsider buy: Chief Financial Officer
Aug 27SEC8-K filed: material event
Aug 19SEC10-Q filed

Sign up to see the real CSLLY record →

Company facts

SEC EDGAR registration

Name: CSL LTD
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +58sample, -100 to +100
Reporting currency: USD

Who is positioning in CSLLY

sample

Insiders: 15 insider transactions over 90 days, net selling, $367.8M
Congress: No member trades over 90 days
Institutions · 13F: 5 funds hold $10.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.0B +20.6% y/y

Q4 2024Q3 2026

Inventory$12.0B +6.9% y/y

Q4 2024Q3 2026

Accounts receivable$9.0B +2.8% y/y

Q4 2024Q3 2026

Total debt$24.8B +13.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $550.1B +13.8% 3M
Sample peer B: $573.3B -3.7% 3M
Sample peer C: $133.7B +14.1% 3M
Sample peer D: $576.5B -12.9% 3M
Sample peer E: $525.7B +5.3% 3M